Jason R Kelly Ginkgo Bioworks Holdings, Inc. (DNA) insider trading activity

DNA Quotes by TradingView

Jason R Kelly is Director of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 3.89 Million shares of DNA, which is worth approximately $42.1 Million. The most recent transaction as insider was on Oct 28, 2022, when has been sold 199,307 shares (Class A Common Stock) at a price of $2.63 per share, resulting in proceeds of $524,177. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.89M
0% 3M change
0% 12M change
Total Value Held $42.1 Million

Jason R Kelly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 28 2022
SELL
Open market or private sale
$524,177 $2.63 p/Share
199,307 Reduced 0.85%
23,174,272 Class A Common Stock
Oct 27 2022
SELL
Open market or private sale
$554,135 $2.71 p/Share
204,478 Reduced 0.87%
23,373,579 Class A Common Stock
Oct 26 2022
SELL
Open market or private sale
$548,500 $2.9 p/Share
189,138 Reduced 0.8%
23,578,057 Class A Common Stock
Oct 25 2022
SELL
Open market or private sale
$494,847 $2.64 p/Share
187,442 Reduced 0.78%
23,767,195 Class A Common Stock
Oct 24 2022
SELL
Open market or private sale
$512,130 $2.48 p/Share
206,504 Reduced 0.85%
23,954,637 Class A Common Stock
Oct 21 2022
SELL
Open market or private sale
$491,345 $2.44 p/Share
201,371 Reduced 0.83%
24,161,141 Class A Common Stock
Oct 20 2022
SELL
Open market or private sale
$485,901 $2.47 p/Share
196,721 Reduced 0.8%
24,362,512 Class A Common Stock
Oct 19 2022
SELL
Open market or private sale
$529,572 $2.5 p/Share
211,829 Reduced 0.86%
24,559,233 Class A Common Stock
Oct 18 2022
SELL
Open market or private sale
$522,855 $2.64 p/Share
198,051 Reduced 0.79%
24,771,062 Class A Common Stock
Oct 17 2022
SELL
Open market or private sale
$515,637 $2.64 p/Share
195,317 Reduced 0.78%
24,969,113 Class A Common Stock
Oct 14 2022
SELL
Open market or private sale
$565,784 $2.62 p/Share
215,948 Reduced 0.85%
25,164,430 Class A Common Stock
Oct 13 2022
SELL
Open market or private sale
$567,923 $2.74 p/Share
207,271 Reduced 0.81%
25,380,378 Class A Common Stock
Oct 12 2022
SELL
Open market or private sale
$593,095 $2.81 p/Share
211,066 Reduced 0.82%
25,587,649 Class A Common Stock
Oct 11 2022
SELL
Open market or private sale
$575,248 $2.87 p/Share
200,435 Reduced 0.77%
25,798,715 Class A Common Stock
Oct 10 2022
SELL
Open market or private sale
$615,096 $2.88 p/Share
213,575 Reduced 0.81%
25,999,150 Class A Common Stock
Oct 03 2022
SELL
Open market or private sale
$1,070,416 $3.12 p/Share
343,082 Reduced 1.29%
26,212,725 Class A Common Stock
Oct 01 2022
BUY
Exercise of conversion of derivative security
-
25,782,354 Added 49.26%
26,555,807 Class A Common Stock
Sep 30 2022
BUY
Exercise of conversion of derivative security
-
773,453 Added 50.0%
773,453 Class A Common Stock
Dec 07 2021
SELL
Bona fide gift
-
150,000 Reduced 100.0%
0 Class A Common Stock
Dec 06 2021
BUY
Conversion of derivative security
-
150,000 Added 50.0%
150,000 Class A Common Stock
JRK

Jason R Kelly

Director
Boston, MA

Track Institutional and Insider Activities on DNA

Follow Ginkgo Bioworks Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DNA